+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Screening and identification of small molecule inhibitors of ErbB2-induced invasion



Screening and identification of small molecule inhibitors of ErbB2-induced invasion



Molecular Oncology 8(8): 1703-1718



ERBB2 amplification and overexpression are strongly associated with invasive cancer with high recurrence and poor prognosis. Enhanced ErbB2 signaling induces cysteine cathepsin B and L expression leading to their higher proteolytic activity (zFRase activity), which is crucial for the invasion of ErbB2-positive breast cancer cells in vitro. Here we introduce a simple screening system based on zFRase activity as a primary readout and a following robust invasion assay and lysosomal distribution analysis for the identification of compounds that can inhibit ErbB2-induced invasion. With an unbiased kinase inhibitor screen, we identified Bohemine/Roscovitine, Gö6979 and JAK3 inhibitor VI as compounds that can efficiently decrease cysteine cathepsin activity. Using the well-established and clinically relevant ErbB1 and ErbB2 inhibitor lapatinib as a positive control, we studied their ability to inhibit ErbB2-induced invasion in 3-dimensional Matrigel cultures. We found one of them, JAK3 inhibitor VI, capable of inhibiting invasion of highly invasive ErbB2-positive ovarian cancer cells as efficiently as lapatinib, whereas Gö6979 and Roscovitine displayed more modest inhibition. All compounds reversed the malignant, ErbB2-induced and invasion-supporting peripheral distribution of lysosomes. This effect was most evident for lapatinib and JAK3 inhibitor VI and milder for Gö6979 and Roscovitine. Our results further showed that JAK3 inhibitor VI function was independent of JAK kinases but involved downregulation of cathepsin L. We postulate that the screening method and the verification experiments that are based on oncogene-induced changes in lysosomal hydrolase activity and lysosomal distribution could be used for identification of novel inhibitors of ErbB2-induced invasiveness. Additionally, we introduce a novel function for lapatinib in controlling malignant lysosomal distribution, that may also be involved in its capability to inhibit ErbB2-induced invasion in vivo.

(PDF emailed within 0-6 h: $19.90)

Accession: 055670223

Download citation: RISBibTeXText

PMID: 25070180

DOI: 10.1016/j.molonc.2014.07.004


Related references

Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening. Bioscience Trends 6(4): 192-200, 2013

Identification of small molecule inhibitors of neurite loss induced by Aβ peptide using high content screening. Journal of Biological Chemistry 287(12): 8714-8723, 2012

Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion. Molecular Cancer Therapeutics 7(10): 3352-3362, 2008

Identification of novel small molecule inhibitors of the XPA protein using in silico based screening. Acs Chemical Biology 5(10): 953-965, 2011

Identification of Drug-Like Inhibitors of Insulin-Regulated Aminopeptidase Through Small-Molecule Screening. Assay and Drug Development Technologies 14(3): 180-193, 2016

Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid. Bioorganic & Medicinal Chemistry 19(1): 77-90, 2011

Identification of small molecule inhibitors of p27Kip1 ubiquitination by high-throughput screening. 2013

Identification of new GATA4-small molecule inhibitors by structure-based virtual screening. Bioorganic & Medicinal Chemistry 19(5): 1734-1742, 2011

High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Research 134(): 6-16, 2016

A high throughput screening assay system for the identification of small molecule inhibitors of gsp. Plos One 9(3): E90766-E90766, 2015

Identification of small molecule inhibitors of p27(Kip1) ubiquitination by high-throughput screening. Cancer Science 104(11): 1461-1467, 2014

Identification of Small Molecule Inhibitors of BCR/ABL Tyrosine Kinase through Structure Based Virtual Screening. Blood 100(11): Abstract No 1234, November 16, 2002

First identification of small-molecule inhibitors of Pontin by combining virtual screening and enzymatic assay. Biochemical Journal 443(2): 549-559, 2012

Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation. Plos One 10(9): E0138780-E0138780, 2016

Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening. Toxicology in Vitro 24(5): 1404-1409, 2010